When dogs are invaded with Babesia, metabolic and detoxification processes are disrupted. In this regard, the therapeutic regimen should include drugs that contribute to the normalization of metabolism, and maintenance of liver and kidney function. The purpose of our research was to study the effects of Аminotone on the hematological and biochemical status of dogs during the treatment of babesiosis. For this purpose, Forticarb was administered as an etiological agent to the animals of the control group, and Аminotone was additionally administered to the experimental dogs. Before the experiment and two weeks after the beginning of the treatment, blood was taken from the dogs for hematological and biochemical studies. It was found that the control and experimental animals showed a decrease in leukocytes, ESR, ALT and AST activity, urea, and creatinine and bilirubin concentrations after the recovery. At the same time, an increase in erythrocytes, hematocrit, mean corpuscular volume and hemoglobin was recorded. Аminotone provided more intensive changes in the dogs’ biochemical and hematological status: reduced inflammatory reaction, toxic load on the liver and kidneys, and stimulated hematopoiesis, versus the control. Thus, the drug can be recommended for the combined therapy of canine babesiosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.